Aberrant expression of the sodium-iodide symporter (NIS) and the resistance to post-operative radioactive iodide treatment is a crucial cause of higher mortality of some thyroid cancer patients. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.